Study of VX-770 on Desipramine

Clinical trial NCT01153542 · COMPLETED

Trial details

NCT number: NCT01153542
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

In Development for Cystic Fibrosis

Start date: 2010-06-01
Primary completion: 2010-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.